Nasal Polyps Treatment Market
1 Introduction to Research & Analysis Reports
1.1 Nasal Polyps Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasal Polyps Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasal Polyps Treatment Overall Market Size
2.1 Global Nasal Polyps Treatment Market Size: 2021 VS 2028
2.2 Global Nasal Polyps Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nasal Polyps Treatment Players in Global Market
3.2 Top Global Nasal Polyps Treatment Companies Ranked by Revenue
3.3 Global Nasal Polyps Treatment Revenue by Companies
3.4 Top 3 and Top 5 Nasal Polyps Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nasal Polyps Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nasal Polyps Treatment Players in Global Market
3.6.1 List of Global Tier 1 Nasal Polyps Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Nasal Polyps Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nasal Polyps Treatment Market Size Markets, 2021 & 2028
4.1.2 Pharmacological Therapies
4.1.3 Surgeries
4.2 By Type - Global Nasal Polyps Treatment Revenue & Forecasts
4.2.1 By Type - Global Nasal Polyps Treatment Revenue, 2017-2022
4.2.2 By Type - Global Nasal Polyps Treatment Revenue, 2023-2028
4.2.3 By Type - Global Nasal Polyps Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasal Polyps Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.2 By Application - Global Nasal Polyps Treatment Revenue & Forecasts
5.2.1 By Application - Global Nasal Polyps Treatment Revenue, 2017-2022
5.2.2 By Application - Global Nasal Polyps Treatment Revenue, 2023-2028
5.2.3 By Application - Global Nasal Polyps Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nasal Polyps Treatment Market Size, 2021 & 2028
6.2 By Region - Global Nasal Polyps Treatment Revenue & Forecasts
6.2.1 By Region - Global Nasal Polyps Treatment Revenue, 2017-2022
6.2.2 By Region - Global Nasal Polyps Treatment Revenue, 2023-2028
6.2.3 By Region - Global Nasal Polyps Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nasal Polyps Treatment Revenue, 2017-2028
6.3.2 US Nasal Polyps Treatment Market Size, 2017-2028
6.3.3 Canada Nasal Polyps Treatment Market Size, 2017-2028
6.3.4 Mexico Nasal Polyps Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nasal Polyps Treatment Revenue, 2017-2028
6.4.2 Germany Nasal Polyps Treatment Market Size, 2017-2028
6.4.3 France Nasal Polyps Treatment Market Size, 2017-2028
6.4.4 U.K. Nasal Polyps Treatment Market Size, 2017-2028
6.4.5 Italy Nasal Polyps Treatment Market Size, 2017-2028
6.4.6 Russia Nasal Polyps Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Nasal Polyps Treatment Market Size, 2017-2028
6.4.8 Benelux Nasal Polyps Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nasal Polyps Treatment Revenue, 2017-2028
6.5.2 China Nasal Polyps Treatment Market Size, 2017-2028
6.5.3 Japan Nasal Polyps Treatment Market Size, 2017-2028
6.5.4 South Korea Nasal Polyps Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Nasal Polyps Treatment Market Size, 2017-2028
6.5.6 India Nasal Polyps Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nasal Polyps Treatment Revenue, 2017-2028
6.6.2 Brazil Nasal Polyps Treatment Market Size, 2017-2028
6.6.3 Argentina Nasal Polyps Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nasal Polyps Treatment Revenue, 2017-2028
6.7.2 Turkey Nasal Polyps Treatment Market Size, 2017-2028
6.7.3 Israel Nasal Polyps Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Nasal Polyps Treatment Market Size, 2017-2028
6.7.5 UAE Nasal Polyps Treatment Market Size, 2017-2028
7 Players Profiles
7.1 OptiNose US
7.1.1 OptiNose US Corporate Summary
7.1.2 OptiNose US Business Overview
7.1.3 OptiNose US Nasal Polyps Treatment Major Product Offerings
7.1.4 OptiNose US Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.1.5 OptiNose US Key News
7.2 Regeneron Pharmaceuticals
7.2.1 Regeneron Pharmaceuticals Corporate Summary
7.2.2 Regeneron Pharmaceuticals Business Overview
7.2.3 Regeneron Pharmaceuticals Nasal Polyps Treatment Major Product Offerings
7.2.4 Regeneron Pharmaceuticals Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.2.5 Regeneron Pharmaceuticals Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Nasal Polyps Treatment Major Product Offerings
7.3.4 Merck Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Nasal Polyps Treatment Major Product Offerings
7.4.4 Pfizer Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 F. Hoffmann La-Roche
7.5.1 F. Hoffmann La-Roche Corporate Summary
7.5.2 F. Hoffmann La-Roche Business Overview
7.5.3 F. Hoffmann La-Roche Nasal Polyps Treatment Major Product Offerings
7.5.4 F. Hoffmann La-Roche Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.5.5 F. Hoffmann La-Roche Key News
7.6 Intersect ENT
7.6.1 Intersect ENT Corporate Summary
7.6.2 Intersect ENT Business Overview
7.6.3 Intersect ENT Nasal Polyps Treatment Major Product Offerings
7.6.4 Intersect ENT Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.6.5 Intersect ENT Key News
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporate Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Nasal Polyps Treatment Major Product Offerings
7.7.4 GlaxoSmithKline Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.7.5 GlaxoSmithKline Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Nasal Polyps Treatment Major Product Offerings
7.8.4 Sanofi Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Nasal Polyps Treatment Major Product Offerings
7.9.4 Novartis Nasal Polyps Treatment Revenue in Global Market (2017-2022)
7.9.5 Novartis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Nasal Polyps Treatment Market Opportunities & Trends in Global Market
Table 2. Nasal Polyps Treatment Market Drivers in Global Market
Table 3. Nasal Polyps Treatment Market Restraints in Global Market
Table 4. Key Players of Nasal Polyps Treatment in Global Market
Table 5. Top Nasal Polyps Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nasal Polyps Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nasal Polyps Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nasal Polyps Treatment Product Type
Table 9. List of Global Tier 1 Nasal Polyps Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasal Polyps Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Nasal Polyps Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nasal Polyps Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nasal Polyps Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Nasal Polyps Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nasal Polyps Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nasal Polyps Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Nasal Polyps Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nasal Polyps Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nasal Polyps Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nasal Polyps Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nasal Polyps Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nasal Polyps Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nasal Polyps Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nasal Polyps Treatment Revenue, (US$, Mn), 2023-2028
Table 30. OptiNose US Corporate Summary
Table 31. OptiNose US Nasal Polyps Treatment Product Offerings
Table 32. OptiNose US Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Regeneron Pharmaceuticals Corporate Summary
Table 34. Regeneron Pharmaceuticals Nasal Polyps Treatment Product Offerings
Table 35. Regeneron Pharmaceuticals Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Nasal Polyps Treatment Product Offerings
Table 38. Merck Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Nasal Polyps Treatment Product Offerings
Table 41. Pfizer Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann La-Roche Corporate Summary
Table 43. F. Hoffmann La-Roche Nasal Polyps Treatment Product Offerings
Table 44. F. Hoffmann La-Roche Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Intersect ENT Corporate Summary
Table 46. Intersect ENT Nasal Polyps Treatment Product Offerings
Table 47. Intersect ENT Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Nasal Polyps Treatment Product Offerings
Table 50. GlaxoSmithKline Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Nasal Polyps Treatment Product Offerings
Table 53. Sanofi Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Novartis Corporate Summary
Table 55. Novartis Nasal Polyps Treatment Product Offerings
Table 56. Novartis Nasal Polyps Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Nasal Polyps Treatment Segment by Type in 2021
Figure 2. Nasal Polyps Treatment Segment by Application in 2021
Figure 3. Global Nasal Polyps Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nasal Polyps Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nasal Polyps Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nasal Polyps Treatment Revenue in 2021
Figure 8. By Type - Global Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 12. US Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 24. China Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nasal Polyps Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nasal Polyps Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. OptiNose US Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Regeneron Pharmaceuticals Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann La-Roche Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Intersect ENT Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis Nasal Polyps Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
